Membership

Categories

View All
Autoimmune Diseases Brain Health Cardiovascular Health Metals Microbes Women’s Health

Conditions

View All
Alzheimer’s Dementia Anemia Autism spectrum disorder (ASD) Bacterial Vaginosis Breast Cancer Chronic Kidney Disease (CKD) Chronic Pelvic Pain (CPP) Crohn’s Disease Diabetes Type I End-Stage Renal Disease (ESRD) Endometriosis Erectile Dysfunction Female Infertility Graves’ Disease (GD) Hashimoto’s Thyroiditis

Definitions

View All
Aflatoxin Amsel’s Criteria Autoantibodies Blood-Brain Barrier (BBB) Bradford Hill Criteria Calprotectin Chelation Coelomic Metaplasia Theory Colibactin Drug Repurposing  EDTA Endometriomas Environmental Theory of Endometriosis Estrobolome Estrogen

Guides & Resources

View All
Endometriosis Guide Microbiome Diet for Endometriosis

Interventions

View All
Boric Acid Cholestyramine Clindamycin Clinoptilolite Zeolite Dimethylglyoxime (DMG) Hyperbaric Oxygen Therapy (HBOT) Lactoferrin Lactulose Low‑Nickel Diet (LNiD) Lugdunin Metformin Metronidazole Phage Therapy Photobiomodulation Probiotics

Supplements

View All
Essential Oils Flavones and Flavonols Guar Gum Pueraria Flower Extract (PFE)

Microbes

View All
E. coli Nissle 1917 Escherichia coli (E. coli) H pylori Microsporum canis (M. canis) Pseudomonas aeruginosa Staphylococcus aureus (S. Aureus) Streptococcus agalactiae (GBS) Streptococcus spp. Ureaplasma urealyticum (U. urealyticum)

Metals

View All
Arsenic (As) Cadmium (Cd) Copper (Cu) Gallium Iron (Fe) Lead (Pb) Mercury Metalloestrogens Nickel Nickel in Escherichia coli: Metabolic and Pathogenic Roles Zinc

Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Fecal calprotectin biomarker in IBD: Clinical Use Increased intestinal absorption of foreign organic compounds in the presence of ethylenediaminetetraacetic acid (EDTA) Cytochrome c-549-an endogenous cofactor of cyclic photophosphorylation in the cyanobacterium Anacystis nidulans? Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children Cadmium transport in blood serum Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease

Posts tagged with "Alzheimer’s disease" (A-Z)

A C D G I M O P S
G
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
O
Oral microbiota changes in elderly patients, an indicator of Alzheimer’s disease
G
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.
C
Classifying dementia progression using microbial profiling of saliva
S
Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer’s Disease
O
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer’s Disease
M
Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System
Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota
A
Analysis of Salivary Microbiome in Patients with Alzheimer’s Disease
G
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment
A
Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
S
Stratification of the Gut Microbiota Composition Landscape across the Alzheimer’s Disease Continuum in a Turkish Cohort
D
Disturbed microbial ecology in Alzheimer’s disease: evidence from the gut microbiota and fecal metabolome
I
Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease
P
Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer’s disease
A
Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Yes, I want to help shape the future of microbiome medicine.